Previous close | 2.6000 |
Open | 2.6000 |
Bid | 1.9100 x 200 |
Ask | 3.3200 x 200 |
Day's range | 2.5800 - 2.6500 |
52-week range | 1.8460 - 4.1500 |
Volume | |
Avg. volume | 13,687 |
Market cap | 82.52M |
Beta (5Y monthly) | 1.10 |
PE ratio (TTM) | 29.44 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
NEWTOWN, PA, April 14, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Forian Inc. (Nasdaq:FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, is deeply saddened to announce the passing of its director, Martin J. Wygod (Marty), on Friday at age 84. Marty was a healthcare entrepreneur, thoroughbred horse breeder and philanthropist. He is the father of Forian Executive Chairman, Chief Executive Officer and President, Max Wygod.
Full Year 2023 Revenue Grew 25% Full Year 2023 Adjusted EBITDA of $2.3MM NEWTOWN, PA, March 28, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Forian Inc. (Nasdaq: FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, today announced results for the quarter and year ended December 31, 2023. “Forian finished the year by executing against our quarterly plan and closed what was a transformational year,” stated Max Wygod, Chairman
NEWTOWN, PA, March 08, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Forian Inc. (Nasdaq: FORA), a provider of data science driven information and analytics solutions to the healthcare and life sciences industries, will announce its fourth quarter and full year 2023 financial results on Thursday, March 28, 2024, after the close of the market. The Company will host a conference call and webcast at 4:30 p.m. (ET) on March 28, 2024, to discuss the results. To register for the conference call, click